中华航海医学与高气压医学杂志
中華航海醫學與高氣壓醫學雜誌
중화항해의학여고기압의학잡지
Chinese Journal of Nautical Medicine and Hyperbaric Medicine
2015年
5期
378-381
,共4页
杨艳艳%梅厚东%刘家传%刘克万%王金标%孙文江%李俊
楊豔豔%梅厚東%劉傢傳%劉剋萬%王金標%孫文江%李俊
양염염%매후동%류가전%류극만%왕금표%손문강%리준
脑弥漫性轴索损伤%磁共振成像%磁共振波谱学%高压氧治疗
腦瀰漫性軸索損傷%磁共振成像%磁共振波譜學%高壓氧治療
뇌미만성축색손상%자공진성상%자공진파보학%고압양치료
Diffuse axonal injury%Magnetic resonance imaging%Magnetic resonance spectroscopy%Hyperbaric oxygen therapy
目的 探讨不同压力高压氧治疗对重型弥漫性轴索损伤的治疗价值及对预后的影响.方法 收集我院2013年9月至2015年3月收治的30例弥漫性轴索损伤患者,按照数字表法随机分成对照组、0.20 MPa组和0.25 MPa组,每组各10例.对照组仅予以常规治疗,0.20 MPa组在常规治疗基础上待生命体征稳定后给予3个疗程0.2 MPa治疗,0.25 MPa组给予3个疗程0.25 MPa治疗.采用GOS评分、NIHSS评分评价各组患者神经功能.应用磁共振波谱观察3组胼胝体压部和基底节N-乙酰天冬氨酸(N-acetylaspartate,NAA)/肌酸和磷酸肌酸(creatine compound,Cr)、胆碱复合物(cholinecontaining compounds,Cho)/Cr、肌醇(mINs)/Cr等指标的差异.结果 0.25 MPa组(18.450,8.09±4.35)与0.20 MPa组(16.630,12.05±2.15)及对照组(12.040,13.35 ±2.34)比较GOS评分及NIHSS评分差异均有统计学意义(P<0.05或P<0.01).0.25 MPa组伤后3个月胼胝体压部NAA/Cr、Cho/Cr、mlNs/Cr、基底节区NAA/Cr、Cho/Cr,与0.20 MPa组和对照组相比,差异均有统计学意义(P <0.05或P<0.01).结论 对于重型弥漫性轴索损伤患者,高压氧治疗可改善胼胝体压部及基底节区脑组织代谢,改善神经功能缺损与患者预后.
目的 探討不同壓力高壓氧治療對重型瀰漫性軸索損傷的治療價值及對預後的影響.方法 收集我院2013年9月至2015年3月收治的30例瀰漫性軸索損傷患者,按照數字錶法隨機分成對照組、0.20 MPa組和0.25 MPa組,每組各10例.對照組僅予以常規治療,0.20 MPa組在常規治療基礎上待生命體徵穩定後給予3箇療程0.2 MPa治療,0.25 MPa組給予3箇療程0.25 MPa治療.採用GOS評分、NIHSS評分評價各組患者神經功能.應用磁共振波譜觀察3組胼胝體壓部和基底節N-乙酰天鼕氨痠(N-acetylaspartate,NAA)/肌痠和燐痠肌痠(creatine compound,Cr)、膽堿複閤物(cholinecontaining compounds,Cho)/Cr、肌醇(mINs)/Cr等指標的差異.結果 0.25 MPa組(18.450,8.09±4.35)與0.20 MPa組(16.630,12.05±2.15)及對照組(12.040,13.35 ±2.34)比較GOS評分及NIHSS評分差異均有統計學意義(P<0.05或P<0.01).0.25 MPa組傷後3箇月胼胝體壓部NAA/Cr、Cho/Cr、mlNs/Cr、基底節區NAA/Cr、Cho/Cr,與0.20 MPa組和對照組相比,差異均有統計學意義(P <0.05或P<0.01).結論 對于重型瀰漫性軸索損傷患者,高壓氧治療可改善胼胝體壓部及基底節區腦組織代謝,改善神經功能缺損與患者預後.
목적 탐토불동압력고압양치료대중형미만성축색손상적치료개치급대예후적영향.방법 수집아원2013년9월지2015년3월수치적30례미만성축색손상환자,안조수자표법수궤분성대조조、0.20 MPa조화0.25 MPa조,매조각10례.대조조부여이상규치료,0.20 MPa조재상규치료기출상대생명체정은정후급여3개료정0.2 MPa치료,0.25 MPa조급여3개료정0.25 MPa치료.채용GOS평분、NIHSS평분평개각조환자신경공능.응용자공진파보관찰3조변지체압부화기저절N-을선천동안산(N-acetylaspartate,NAA)/기산화린산기산(creatine compound,Cr)、담감복합물(cholinecontaining compounds,Cho)/Cr、기순(mINs)/Cr등지표적차이.결과 0.25 MPa조(18.450,8.09±4.35)여0.20 MPa조(16.630,12.05±2.15)급대조조(12.040,13.35 ±2.34)비교GOS평분급NIHSS평분차이균유통계학의의(P<0.05혹P<0.01).0.25 MPa조상후3개월변지체압부NAA/Cr、Cho/Cr、mlNs/Cr、기저절구NAA/Cr、Cho/Cr,여0.20 MPa조화대조조상비,차이균유통계학의의(P <0.05혹P<0.01).결론 대우중형미만성축색손상환자,고압양치료가개선변지체압부급기저절구뇌조직대사,개선신경공능결손여환자예후.
Objective To investigate the value of different pressure hyperbaric oxygen (HBO) therapy on clinical outcomes and effect on prognosis of the patients with severe diffuse axonal injury (DAI).Methods Thirty cases of diffuse axonal injury admitted into our hospital from September 2013 to March 2015 were randomly divided into 3 groups: the control group, the lower hyperbaric oxygen group (or the lower HBO group) and the higher hyperbaric oxygen group (or the higher HBO group) , each consisting of 10 cases.The control group was just given routine treatment, the lower HBO group received 3 courses of 0.2 MPa HBO therapy in addition to routine treatment after vital signs became stable, and the higher HBO group received 3 courses of 0.25 MPa HBO therapy in addition to routine treatment.Neural functions of the 3 groups were evaluated by using GOS and NIHSS.Magnetic resonance spectroscopy was used to observe changes in the indicators of N-acetylaspartate (NAA)/ creatine (Cr), choline-containing compounds (Cho)/Cr and mINs/Cr.Results Statistical differences could be seen in the scores of GOS and NIHSS, when comparisons were made between the groups (P <0.05 or P <0.01).As compared with those of the lower HBO group and the control group, the levels of NAA/Cr, Cho/Cr, mlNs/Cr in the splenium of corpus callosumin, and NAA/Cr and Cho/Cr in basal ganglia for the 0.25 MPa HBO group were either elevated or decreased, with statistical significance (P < 0.05 or P < 0.01).Conclusions For the patients with severe diffuse axonal injury, higher pressure HBO therapy could obviously enhance metabolism of brain tissues in the splenium of corpus callosumin and basal ganglia and improve neurological deficits prognosis of the disorder.